IRIS - Res&Arch Institutional Research Information System - Research & Archive

VOLPI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.125
EU - Europa 2.716
AS - Asia 2.156
SA - Sud America 323
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 8.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.041
SG - Singapore 899
IT - Italia 858
HK - Hong Kong 369
CN - Cina 368
IE - Irlanda 366
VN - Vietnam 282
BR - Brasile 274
DE - Germania 231
RU - Federazione Russa 207
RO - Romania 193
SE - Svezia 171
UA - Ucraina 161
FR - Francia 134
FI - Finlandia 121
KR - Corea 72
GB - Regno Unito 71
CA - Canada 54
IN - India 44
CZ - Repubblica Ceca 42
BE - Belgio 39
NL - Olanda 28
PL - Polonia 27
JP - Giappone 26
AR - Argentina 22
MX - Messico 19
TR - Turchia 19
CH - Svizzera 17
ES - Italia 16
CI - Costa d'Avorio 15
AT - Austria 13
EG - Egitto 12
ZA - Sudafrica 11
IR - Iran 10
BD - Bangladesh 9
GR - Grecia 9
UZ - Uzbekistan 9
MA - Marocco 8
EC - Ecuador 7
VE - Venezuela 7
IQ - Iraq 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 5
LT - Lituania 5
PK - Pakistan 5
LB - Libano 4
CO - Colombia 3
EU - Europa 3
KZ - Kazakistan 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
DK - Danimarca 2
EE - Estonia 2
GT - Guatemala 2
KE - Kenya 2
LK - Sri Lanka 2
PH - Filippine 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
TH - Thailandia 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CL - Cile 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
SR - Suriname 1
SV - El Salvador 1
TW - Taiwan 1
UY - Uruguay 1
Totale 8.380
Salva come PNG Salva come JPEG
Città #
Singapore 613
Perugia 505
Chandler 412
Hong Kong 368
Dublin 361
Dong Ket 200
San Mateo 194
Bucharest 175
Ashburn 171
Boardman 162
Santa Clara 136
Redmond 122
Munich 119
Beijing 94
Los Angeles 83
Medford 79
Wilmington 79
Altamura 78
Princeton 78
Jacksonville 77
Seoul 69
Moscow 68
Ann Arbor 63
Lawrence 62
New York 52
Andover 50
Falls Church 43
Brussels 39
The Dalles 35
Turku 34
Dearborn 33
Des Moines 30
São Paulo 30
Dallas 28
Ho Chi Minh City 27
Piscataway 27
Rome 27
Brno 26
Pisa 26
Chennai 25
Helsinki 25
Montreal 22
Norwalk 22
Saint Petersburg 22
Poplar 20
Warsaw 20
Stockholm 19
Tokyo 19
Brooklyn 17
Chicago 17
Denver 17
Chiajna 16
Hanoi 16
Abidjan 15
Fremont 15
Nuremberg 15
Woodbridge 15
Boston 14
Hefei 14
Houston 14
Izmir 14
Olomouc 14
San Paolo di Civitate 14
Atlanta 11
Columbus 11
Johannesburg 11
Phoenix 11
Redwood City 11
Curitiba 10
Florence 10
Lappeenranta 10
Milan 10
Seattle 10
Frankfurt am Main 9
Manchester 9
San Diego 9
Amsterdam 8
Nanjing 8
Orem 8
San Francisco 8
Toronto 8
Bologna 7
Brasília 7
Den Haag 7
Falkenstein 7
Guangzhou 7
Ottawa 7
Querétaro 7
Rio de Janeiro 7
San Jose 7
Vicenza 7
Vienna 7
Chengdu 6
London 6
Belo Horizonte 5
Haiphong 5
Hanover 5
Menlo Park 5
Mexico City 5
Secaucus 5
Totale 5.587
Salva come PNG Salva come JPEG
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 187
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 177
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 173
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 165
Amino-acid sensing and degrading pathways in immune regulation 162
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 158
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 155
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 151
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 149
Amino acid metabolism as drug target in autoimmune diseases 148
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 142
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 136
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 135
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 132
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 125
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 125
Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. 124
Artocarpus tonkinensis extract inhibits LPS-triggered inflammation markers and suppresses RANKL-induced osteoclastogenesis in RAW264.7 119
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 115
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 113
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 112
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 111
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 111
A TLR9/TRIF pathway induces tolerance via TGF-beta and tryptophan catabolism in plasmacytoid dendritic cells 110
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 108
A novel metabotropic glutamate receptor 4 allosteric modulator effective in multiple sclerosis experimental autoimmune encephalomyelitis (EAE) mouse model 107
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 106
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 104
Onion (Allium cepa L.) Skin: A rich resource of biomolecules for the sustainable production of colored biofunctional textiles 102
Anti-osteoclastogenic activity of Crocus sativus petal extract: turning saffron waste into a valuable resource against bone disruption. 102
A back-door insight into the modulation of Src kinase activity by the polyamine spermidine 101
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 101
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 101
The TGF-β/IDO axis in infectious tolerance. 100
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 98
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 97
Use of a Zwitterionic Surfactant to Improve the Biofunctional Properties of Wool Dyed with an Onion (Allium cepa L.) Skin Extract 94
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 93
CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis 87
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 86
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 86
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 85
Optimization of Ultrasound-Assisted Extraction of Chlorogenic Acid from Potato Sprout Waste and Enhancement of the In Vitro Total Antioxidant Capacity 84
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 84
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 83
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 83
Crocus sativus L. Petal Extract Inhibits Inflammation and Osteoclastogenesis in RAW 264.7 Cell Model 83
CTLA-4-immunoglobulin and indoleamine 2,3 dioxygenase in dominant tolerance. 82
Anti-inflammatory and anti-osteoclastogenic activity of a Crocus sativus petal extract targeting macrophages: from waste to raw material on the way to preventing bone loss. Maria 81
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 80
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 80
MARS: A Multipurpose Software for Untargeted LC–MS-Based Metabolomics and Exposomics 77
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 77
Differentiation of Myeloid-derived Suppressor Cells from Murine Bone Marrow and Their Co-culture with Splenic Dendritic Cells 77
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 76
Potential prognostic role of Indoleamine 2,3-dioxygenase 2 in human non-small cell lung cancer: an immunohistochemical study. 75
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. 70
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 69
NEW PERSPECTIVES IN HUMAN NON-SMALL CELL LUNG CANCER: IDO2 AS A POTENTIAL PROGNOSTIC BIOMARKER 69
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 69
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 69
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 69
Antioxidant power on dermal cells by textiles dyed with an onion (Allium cepa L.) skin extract 69
In-depth characterization of phenolic profiling of Moraiolo extra-virgin olive oil extract and initial investigation of the inhibitory effect on Indoleamine-2,3-Dioxygenase (IDO1) enzyme 69
IDO mediates TLR9-driven protection from experimental autoimmune diabetes 68
Generation of protective immune environment in murine models of Multiple Sclerosis by TLR7 and TLR9 agonists 68
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 68
Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme 67
Current Challenges for IDO2 as Target in Cancer Immunotherapy 67
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 66
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 65
Challenges in the design of reliable immuno-oncology mouse models to inform drug development 64
The role of TGF-beta as tolerogenic cytokine in regulating dendritic cell function. 64
Targeting metabotropic glutamate receptors for the treatment of neuroinflammation 64
Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3). 63
Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice 62
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 62
A TLR9/TRIF PATHWAY INDUCES TOLERANCE VIA TGF-β AND TRYPTOPHAN CATABOLISM IN PLASMACYTOID DENDRITIC CELLS 62
A TLR9/TRIF PATHWAY INDUCES TOLERANCE VIA TGF-β AND TRYPTOPHAN CATABOLISM IN PLASMACYTOID DENDRITIC CELLS 62
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 61
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 60
Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation 60
Reply to Han et al.: On track for an IDO1-based personalized therapy in autoimmunity 60
Analysis of Differential TLR Activation in a Mouse Model of Multiple Sclerosis 55
Chromatographic measurement of 3-hydroxyanthranilate 3,4-dioxygenase activity reveals that edaravone can mitigate the formation of quinolinic acid through a direct enzyme inhibition 55
Targeting metabotropic glutamate receptors in neuroimmune communication 53
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 52
Vedere per credere: utilizzo della microscopia per lo studio dell’immunologia 51
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 47
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 46
Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4 45
Decoding the Complex Crossroad of Tryptophan Metabolic Pathways 43
Optimization of a Simple Analytical Workflow to Characterize the Phenolic Fraction from Grape Pomace 42
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 41
Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy. 39
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 37
Anti-inflammatory and anti-osteoclastogenic activity of a Crocus sativus petal extract targeting macrophages: from waste to raw material on the way to preventing bone loss. 34
The double life of serotonin metabolites: in the mood for joining neuronal and immune systems 31
Volumetric Absorptive Microsampling (VAMS) for Targeted LC-MS/MS Determination of Tryptophan-Related Biomarkers 30
The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2) 22
Totale 8.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021492 0 0 0 0 0 37 86 11 74 33 39 212
2021/20221.125 9 145 19 26 36 29 17 213 133 151 100 247
2022/20231.351 84 258 18 114 118 126 4 61 481 16 54 17
2023/2024760 48 74 24 10 13 13 192 17 70 31 96 172
2024/20251.838 33 139 98 131 209 105 130 186 293 86 268 160
2025/20261.901 232 267 220 551 509 122 0 0 0 0 0 0
Totale 8.710